Pearls of knowledge – handling ocular chemical injuries

Introduction Ocular chemical injuries are vision-threatening emergencies that demand immediate, systematic, and phase-specific management. Early intervention, particularly through copious irrigation, is critical to limit progressive tissue damage and preserve vision.Areas covered Acute-phase care focuses on controlling inflammation, preventing epithelial and stromal breakdown, and supporting re-epithelialization. Nonetheless, long-term complications such as limbal stem cell deficiency, corneal scarring, neovascularization, and secondary glaucoma frequently occur. Emerging therapeutics including stem cell–based therapies, nanotechnology-based drug delivery, and anti-angiogenic agents show promise for improving outcomes. Optimal outcomes depend on a multidisciplinary approach integrating corneal, glaucoma, and oculoplastic expertise.Expert opinion Management of severe ocular chemical injury remains challenging, with unmet needs in both cell replacement and inflammation control. Approaches such as allo-SLET, mucosal grafting, MSCs, and iPSC-derived epithelial cells, show promise for restoring the limbal stem cell niche and improving outcomes advanced disease.

Authors

Institutions

Publication Details

Journal
Expert Review of Ophthalmology
Published
2026-11-16
DOI
https://doi.org/10.1080/17469899.2026.2765944
Primary Topic
Corneal Surgery and Treatments
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

Pearls of knowledge – handling ocular chemical injuries

Zarife Jale Yucel, Ali R. Djalilian
Expert Review of Ophthalmology
Corneal Surgery and Treatments
article

Pearls of knowledge – handling ocular chemical injuries

Zarife Jale Yucel, Ali R. Djalilian
article en

Abstract

Introduction Ocular chemical injuries are vision-threatening emergencies that demand immediate, systematic, and phase-specific management. Early intervention, particularly through copious irrigation, is critical to limit progressive tissue damage and preserve vision.Areas covered Acute-phase care focuses on controlling inflammation, preventing epithelial and stromal breakdown, and supporting re-epithelialization. Nonetheless, long-term complications such as limbal stem cell deficiency, corneal scarring, neovascularization, and secondary glaucoma frequently occur. Emerging therapeutics including stem cell–based therapies, nanotechnology-based drug delivery, and anti-angiogenic agents show promise for improving outcomes. Optimal outcomes depend on a multidisciplinary approach integrating corneal, glaucoma, and oculoplastic expertise.Expert opinion Management of severe ocular chemical injury remains challenging, with unmet needs in both cell replacement and inflammation control. Approaches such as allo-SLET, mucosal grafting, MSCs, and iPSC-derived epithelial cells, show promise for restoring the limbal stem cell niche and improving outcomes advanced disease.

Expert Review of Ophthalmology
University of Illinois Chicago (US)
Good health and well-being
Corneal Surgery and Treatments
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon